Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Ability of S100B to predict severity and cranial CT results in children with TBI.

Babcock L, Byczkowski T, Mookerjee S, Bazarian JJ.

Brain Inj. 2012;26(11):1372-80. doi: 10.3109/02699052.2012.694565. Epub 2012 Jun 22.

PMID:
22725661
2.

Inability of S100B to predict postconcussion syndrome in children who present to the emergency department with mild traumatic brain injury: a brief report.

Babcock L, Byczkowski T, Wade SL, Ho M, Bazarian JJ.

Pediatr Emerg Care. 2013 Apr;29(4):458-61. doi: 10.1097/PEC.0b013e31828a202d.

3.

Relationship of serum S100B levels and intracranial injury in children with closed head trauma.

Bechtel K, Frasure S, Marshall C, Dziura J, Simpson C.

Pediatrics. 2009 Oct;124(4):e697-704. doi: 10.1542/peds.2008-1493. Epub 2009 Sep 28.

PMID:
19786430
4.

Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.

Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, Alvarez-García E, Vara-Perez C, Andrade-Olivié MA.

Clin Lab. 2011;57(7-8):587-97.

PMID:
21888023
5.

Serum S100B determination in the management of pediatric mild traumatic brain injury.

Bouvier D, Fournier M, Dauphin JB, Amat F, Ughetto S, Labbé A, Sapin V.

Clin Chem. 2012 Jul;58(7):1116-22. doi: 10.1373/clinchem.2011.180828. Epub 2012 Apr 23.

6.

GFAP and S100B in the acute phase of mild traumatic brain injury.

Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J.

Neurology. 2012 May 1;78(18):1428-33. doi: 10.1212/WNL.0b013e318253d5c7. Epub 2012 Apr 18.

PMID:
22517109
7.

Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.

Geyer C, Ulrich A, Gräfe G, Stach B, Till H.

J Neurosurg Pediatr. 2009 Oct;4(4):339-44. doi: 10.3171/2009.5.PEDS08481.

PMID:
19795965
8.

S100B is not a reliable prognostic index in paediatric TBI.

Piazza O, Storti MP, Cotena S, Stoppa F, Perrotta D, Esposito G, Pirozzi N, Tufano R.

Pediatr Neurosurg. 2007;43(4):258-64.

PMID:
17627141
9.

Multiple indicators model of long-term mortality in traumatic brain injury.

Gradisek P, Osredkar J, Korsic M, Kremzar B.

Brain Inj. 2012;26(12):1472-81. doi: 10.3109/02699052.2012.694567. Epub 2012 Jun 21.

PMID:
22721420
10.

S100B serum level predicts computed tomography findings after minor head injury.

Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T.

J Trauma. 2007 Jun;62(6):1452-6.

PMID:
17563665
11.

Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.

Filippidis AS, Papadopoulos DC, Kapsalaki EZ, Fountas KN.

Neurosurg Focus. 2010 Nov;29(5):E2. doi: 10.3171/2010.8.FOCUS10185. Review.

PMID:
21039136
12.

Accuracy of the S100β protein as a marker of brain damage in traumatic brain injury.

Egea-Guerrero JJ, Revuelto-Rey J, Murillo-Cabezas F, Muñoz-Sánchez MA, Vilches-Arenas A, Sánchez-Linares P, Domínguez-Roldán JM, León-Carrión J.

Brain Inj. 2012;26(1):76-82. doi: 10.3109/02699052.2011.635360.

PMID:
22149446
13.

Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.

da Rocha AB, Schneider RF, de Freitas GR, André C, Grivicich I, Zanoni C, Fossá A, Gehrke JT, Pereira Jotz G, Kaufmann M, Simon D, Regner A.

Clin Chem Lab Med. 2006;44(10):1234-42.

PMID:
17032136
14.

Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article.

Wolf H, Frantal S, Pajenda GS, Salameh O, Widhalm H, Hajdu S, Sarahrudi K.

J Neurosurg. 2013 Jun;118(6):1298-303. doi: 10.3171/2013.1.JNS121181. Epub 2013 Mar 1.

PMID:
23451906
15.

Serum S100B levels in patients with epidural haematomas.

Undén J, Bellner J, Astrand R, Romner B.

Br J Neurosurg. 2005 Feb;19(1):43-5.

PMID:
16147582
16.

The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.

Žurek J, Fedora M.

Acta Neurochir (Wien). 2012 Jan;154(1):93-103; discussion 103. doi: 10.1007/s00701-011-1175-2.

PMID:
21976236
17.

Analysis of S100 calcium binding protein B serum levels in different types of traumatic intracranial lesions.

Wolf H, Frantal S, Pajenda G, Leitgeb J, Sarahrudi K, Hajdu S.

J Neurotrauma. 2015 Jan 1;32(1):23-7. doi: 10.1089/neu.2013.3202.

PMID:
25068442
18.

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.

Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM.

J Neurosurg. 2005 Jul;103(1 Suppl):61-8.

PMID:
16122007
19.

Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.

Bazarian JJ, Blyth BJ, He H, Mookerjee S, Jones C, Kiechle K, Moynihan R, Wojcik SM, Grant WD, Secreti LM, Triner W, Moscati R, Leinhart A, Ellis GL, Khan J.

J Neurotrauma. 2013 Oct 15;30(20):1747-54. doi: 10.1089/neu.2013.2853. Epub 2013 Aug 24.

20.

Reliability of calcium-binding protein S100B measurement toward optimization of hyperosmolal therapy in traumatic brain injury.

Hendoui N, Beigmohammadi MT, Mahmoodpoor A, Ahmadi A, Abdollahi M, Hasanpour M, Hadi F, Khazaeipour Z, Mousavi S, Mojtahedzadeh M.

Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):477-85.

Items per page

Supplemental Content

Write to the Help Desk